Hereditary hemochromatosis: genetic complexity and new diagnostic approaches
- PMID: 16627556
- DOI: 10.1373/clinchem.2006.068684
Hereditary hemochromatosis: genetic complexity and new diagnostic approaches
Abstract
Since the discovery of the hemochromatosis gene (HFE) in 1996, several novel gene defects have been detected, explaining the mechanism and diversity of iron-overload diseases. At least 4 main types of hereditary hemochromatosis (HH) have been identified. Surprisingly, genes involved in HH encode for proteins that all affect pathways centered around liver hepcidin synthesis and its interaction with ferroportin, an iron exporter in enterocytes and macrophages. Hepcidin concentrations in urine negatively correlate with the severity of HH. Cytokine-mediated increases in hepcidin appear to be an important causative factor in anemia of inflammation, which is characterized by sequestration of iron in the macrophage system. For clinicians, the challenge is now to diagnose HH before irreversible damage develops and, at the same time, to distinguish progressive iron overload from increasingly common diseases with only moderately increased body iron stores, such as the metabolic syndrome. Understanding the molecular regulation of iron homeostasis may be helpful in designing innovative and reliable DNA and protein tests for diagnosis. Subsequently, evidence-based diagnostic strategies must be developed, using both conventional and innovative laboratory tests, to differentiate between the various causes of distortions of iron metabolism. This review describes new insights in mechanisms of iron overload, which are needed to understand new developments in diagnostic medicine.
Similar articles
-
[Hereditary haemochromatosis: novel genes, novel diseases and hepcidin].Ned Tijdschr Geneeskd. 2007 May 19;151(20):1121-7. Ned Tijdschr Geneeskd. 2007. PMID: 17557668 Review. Dutch.
-
Iron disorders of genetic origin: a changing world.Trends Mol Med. 2011 Dec;17(12):707-13. doi: 10.1016/j.molmed.2011.07.004. Epub 2011 Aug 20. Trends Mol Med. 2011. PMID: 21862411 Review.
-
Hereditary iron overload: update on pathophysiology, diagnosis, and treatment.Am J Hematol. 2006 Mar;81(3):202-9. doi: 10.1002/ajh.20493. Am J Hematol. 2006. PMID: 16493621 Review.
-
[Non-HFE-related hereditary iron overload].Presse Med. 2007 Sep;36(9 Pt 2):1279-91. doi: 10.1016/j.lpm.2007.01.042. Epub 2007 May 30. Presse Med. 2007. PMID: 17540536 Review. French.
-
Function of the hemochromatosis protein HFE: Lessons from animal models.World J Gastroenterol. 2008 Dec 7;14(45):6893-901. doi: 10.3748/wjg.14.6893. World J Gastroenterol. 2008. PMID: 19058322 Free PMC article.
Cited by
-
The C282Y polymorphism of the hereditary hemochromatosis gene is associated with increased sex hormone-binding globulin and normal testosterone levels in men.J Endocrinol Invest. 2010 Sep;33(8):544-8. doi: 10.1007/BF03346645. Epub 2010 Feb 15. J Endocrinol Invest. 2010. PMID: 20160468
-
Pathogenesis, Diagnosis, and Clinical Implications of Hereditary Hemochromatosis-The Cardiological Point of View.Diagnostics (Basel). 2021 Jul 16;11(7):1279. doi: 10.3390/diagnostics11071279. Diagnostics (Basel). 2021. PMID: 34359361 Free PMC article. Review.
-
Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method.Clin Chim Acta. 2011 Nov 20;412(23-24):2241-7. doi: 10.1016/j.cca.2011.08.014. Epub 2011 Aug 16. Clin Chim Acta. 2011. PMID: 21867695 Free PMC article.
-
Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis.Biomed Res Int. 2013;2013:603786. doi: 10.1155/2013/603786. Epub 2013 Feb 28. Biomed Res Int. 2013. PMID: 23555091 Free PMC article. Review.
-
Non-HFE hemochromatosis.Rev Bras Hematol Hemoter. 2012;34(4):311-6. doi: 10.5581/1516-8484.20120079. Rev Bras Hematol Hemoter. 2012. PMID: 23049448 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical